AU733801B2 - Multiple unit effervescent dosage form - Google Patents
Multiple unit effervescent dosage form Download PDFInfo
- Publication number
- AU733801B2 AU733801B2 AU81357/98A AU8135798A AU733801B2 AU 733801 B2 AU733801 B2 AU 733801B2 AU 81357/98 A AU81357/98 A AU 81357/98A AU 8135798 A AU8135798 A AU 8135798A AU 733801 B2 AU733801 B2 AU 733801B2
- Authority
- AU
- Australia
- Prior art keywords
- effervescent
- dosage form
- layer
- units
- excipients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702533A SE9702533D0 (sv) | 1997-07-01 | 1997-07-01 | New oral formulation |
| SE9702533 | 1997-07-01 | ||
| PCT/SE1998/001209 WO1999001112A1 (en) | 1997-07-01 | 1998-06-22 | Multiple unit effervescent dosage form |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU8135798A AU8135798A (en) | 1999-01-25 |
| AU733801B2 true AU733801B2 (en) | 2001-05-24 |
Family
ID=20407594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU81357/98A Ceased AU733801B2 (en) | 1997-07-01 | 1998-06-22 | Multiple unit effervescent dosage form |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6284271B1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1014952B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2002508781A (cg-RX-API-DMAC10.html) |
| AT (1) | ATE247952T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU733801B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2294744C (cg-RX-API-DMAC10.html) |
| DE (1) | DE69817587T2 (cg-RX-API-DMAC10.html) |
| SE (1) | SE9702533D0 (cg-RX-API-DMAC10.html) |
| WO (1) | WO1999001112A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6489346B1 (en) * | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
| US20050054682A1 (en) * | 1996-01-04 | 2005-03-10 | Phillips Jeffrey O. | Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same |
| US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
| DE19850309A1 (de) * | 1998-10-30 | 2000-05-04 | Lohmann Therapie Syst Lts | Expandierbares gastroretensives Therapiesystem mit verlängerter Magenverweildauer |
| ES2168043B1 (es) * | 1999-09-13 | 2003-04-01 | Esteve Labor Dr | Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido. |
| AU2001232020A1 (en) * | 2000-02-09 | 2001-08-20 | West Pharmaceutical Services Drug Delivery And Clinical Research Centre Limited | Floating drug delivery composition |
| US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
| US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
| WO2002026210A2 (en) * | 2000-09-29 | 2002-04-04 | Geneva Pharmaceuticals Inc. | Proton pump inhibitor formulation |
| JP2004525109A (ja) | 2001-02-15 | 2004-08-19 | キング・ファーマシューティカルズ・インコーポレイティッド | 安定化された甲状腺ホルモン医薬組成物、及びその製法 |
| US6555581B1 (en) | 2001-02-15 | 2003-04-29 | Jones Pharma, Inc. | Levothyroxine compositions and methods |
| DE10111780B8 (de) * | 2001-03-13 | 2005-02-10 | Isaak Dr. Abramov | Brausetablette, Pille oder Dragee, sowie das Verfahren zu ihrer Herstellung |
| US20030198671A1 (en) * | 2001-08-10 | 2003-10-23 | Franz G. Andrew | Levothyroxine compositions having unique plasma AUC properties |
| US7101569B2 (en) | 2001-08-14 | 2006-09-05 | Franz G Andrew | Methods of administering levothyroxine pharmaceutical compositions |
| US20030175337A1 (en) * | 2001-10-29 | 2003-09-18 | Franz G. Andrew | Levothyroxine compositions having unique triiodothyronine Tmax properties |
| WO2003063840A2 (en) * | 2002-01-25 | 2003-08-07 | Santarus, Inc. | Transmucosal delivery of proton pump inhibitors |
| US20030228363A1 (en) * | 2002-06-07 | 2003-12-11 | Patel Mahendra R. | Stabilized pharmaceutical compositons containing benzimidazole compounds |
| WO2004056336A2 (en) * | 2002-12-20 | 2004-07-08 | Ranbaxy Laboratories Limited | Controlled release, multiple unit drug delivery systems |
| EP1608347B1 (en) * | 2003-03-28 | 2014-08-13 | Sigmoid Pharma Limited | Solid oral dosage form containing seamless microcapsules |
| US7314640B2 (en) * | 2003-07-11 | 2008-01-01 | Mongkol Sriwongjanya | Formulation and process for drug loaded cores |
| US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| TW200533391A (en) | 2004-03-25 | 2005-10-16 | Sun Pharmaceutical Ind Ltd | Gastric retention drug delivery system |
| RU2382637C2 (ru) * | 2004-04-30 | 2010-02-27 | Астеллас Фарма Инк. | Фармацевтическая композиция для перорального введения в форме частиц с рассчитанным временем высвобождения и быстро распадающиеся таблетки, содержащие указанную композицию |
| US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US20070292523A1 (en) * | 2004-09-27 | 2007-12-20 | Joey Moodley | Dihydropyrimidine Formulations |
| GB0427455D0 (en) * | 2004-12-15 | 2005-01-19 | Jagotec Ag | Dosage forms |
| US7981908B2 (en) * | 2005-05-11 | 2011-07-19 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
| US7803817B2 (en) * | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
| KR100674622B1 (ko) * | 2005-11-04 | 2007-01-29 | 재단법인 포항산업과학연구원 | 연료전지 발전시스템 |
| FR2902337B1 (fr) * | 2005-12-02 | 2010-09-17 | Vacher Dominique | Comprimes a liberation immediate et leur production |
| US20100297226A1 (en) * | 2006-06-01 | 2010-11-25 | Dexcel Pharma Technologies Ltd. | Multiple unit pharmaceutical formulation |
| EP2046334B1 (en) * | 2006-07-25 | 2014-05-21 | Vecta Ltd. | Compositions and meth0ds for inhibiting gastric acide secretion using derivatives of small dicarboxylic acids in combination with ppi |
| KR20090065524A (ko) * | 2006-09-04 | 2009-06-22 | 파나세아 바이오테크 리미티드 | 프로그래머블 부력전달기술 |
| CA2665226C (en) * | 2006-10-05 | 2014-05-13 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
| EP2061440A2 (en) | 2007-04-04 | 2009-05-27 | Sigmoid Pharma Limited | A pharmaceutical composition of tacrolimus |
| ES2963291T3 (es) * | 2007-04-26 | 2024-03-26 | Sublimity Therapeutics Ltd | Fabricación de múltiples minicápsulas |
| JP2010526053A (ja) * | 2007-05-01 | 2010-07-29 | シグモイド・ファーマ・リミテッド | ニモジピン医薬組成物 |
| HUP0700469A2 (en) * | 2007-07-09 | 2009-04-28 | Richter Gedeon Nyrt | Floating pharmaceutical composition of sustained release containing metronidazol |
| EP2271317B1 (de) | 2008-03-28 | 2017-04-19 | Boehringer Ingelheim International GmbH | Verfahren zur herstellung von säurepellets |
| EP2471518B1 (en) | 2009-05-18 | 2017-08-23 | Sigmoid Pharma Limited | Composition comprising oil drops |
| FR2945947B1 (fr) * | 2009-05-29 | 2011-07-29 | Flamel Tech Sa | Compositions pharmaceutiques flottantes a liberation controlee |
| FR2949061B1 (fr) * | 2009-08-12 | 2013-04-19 | Debregeas Et Associes Pharma | Microgranules flottants |
| EP2464341B1 (en) | 2009-08-12 | 2022-07-06 | Sublimity Therapeutics Limited | Immunomodulatory compositions comprising a polymer matrix and an oil phase |
| GB2481005B (en) * | 2010-06-07 | 2012-08-08 | Cosmetic Warriors Ltd | Surfactant product comprising first and second effervescent materials |
| GB201020032D0 (en) | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
| GB201212010D0 (en) | 2012-07-05 | 2012-08-22 | Sigmoid Pharma Ltd | Formulations |
| WO2014191806A2 (en) * | 2013-05-02 | 2014-12-04 | Effrx Pharmaceuticals Sa | Effervescent formulations that deliver particles which float in the stomach |
| GB201319791D0 (en) | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
| WO2016071515A1 (en) | 2014-11-07 | 2016-05-12 | Sigmoid Pharma Limited | Compositions comprising cyclosporin |
| US20170042806A1 (en) | 2015-04-29 | 2017-02-16 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
| KR20170003414A (ko) * | 2015-06-30 | 2017-01-09 | (주)아모레퍼시픽 | 속붕해형 과립환 모발 세정용 조성물 |
| EP3167879A1 (en) * | 2015-11-10 | 2017-05-17 | Evonik Technochemie GmbH | Gastric retention active delivery systems |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
| WO2025235402A1 (en) | 2024-05-07 | 2025-11-13 | Herbalife International Of America, Inc. | Compositions and methods for effervescent systems with improved stability |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4844905A (en) * | 1986-02-24 | 1989-07-04 | Eisai Co., Ltd. | Granule remaining in stomach |
| EP0257310B1 (en) * | 1986-07-28 | 1992-01-08 | Bio -Dar Ltd. | Tablets made from sustained release microcapsules |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5512411B2 (cg-RX-API-DMAC10.html) | 1974-03-12 | 1980-04-02 | ||
| SE450087B (sv) | 1985-10-11 | 1987-06-09 | Haessle Ab | Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial |
| GB2189698A (en) | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
| US4814178A (en) | 1987-07-01 | 1989-03-21 | Sanford Bolton | Floating sustained release therapeutic compositions |
| US5445826A (en) | 1988-06-28 | 1995-08-29 | Cibus Pharmaceutical, Inc. | Delivery system containing a gel-forming dietary fiber and a drug |
| GB9224021D0 (en) | 1992-11-16 | 1993-01-06 | Boots Co Plc | Effervescent compositions |
| US5503846A (en) | 1993-03-17 | 1996-04-02 | Cima Labs, Inc. | Base coated acid particles and effervescent formulation incorporating same |
| EP0667149A1 (en) | 1994-02-14 | 1995-08-16 | E-PHARMA TRENTO S.p.A. | Ibuprofen based effervescent composition |
| DE4406424A1 (de) | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandierbare Arzneiformen |
| ATE182073T1 (de) | 1994-03-01 | 1999-07-15 | Gerhard Gergely | Ein brausesystem und einen arzneiwirkstoff enthaltendes granuläres produkt bzw. tablette sowie verfahren zu deren herstellung |
| IE940292A1 (en) | 1994-04-06 | 1995-10-18 | Elan Corp Plc | Biodegradable microcapsules and method for their manufacture |
| SE9402422D0 (sv) | 1994-07-08 | 1994-07-08 | Astra Ab | New beads for controlled release and a pharmaceutical preparation containing the same |
| DK1078628T3 (da) | 1994-07-08 | 2009-02-23 | Astrazeneca Ab | Tabletteret flerenhedsdoseringsform |
| SE512835C2 (sv) | 1996-01-08 | 2000-05-22 | Astrazeneca Ab | Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare |
-
1997
- 1997-07-01 SE SE9702533A patent/SE9702533D0/xx unknown
-
1998
- 1998-06-22 WO PCT/SE1998/001209 patent/WO1999001112A1/en not_active Ceased
- 1998-06-22 AT AT98931171T patent/ATE247952T1/de not_active IP Right Cessation
- 1998-06-22 AU AU81357/98A patent/AU733801B2/en not_active Ceased
- 1998-06-22 EP EP98931171A patent/EP1014952B1/en not_active Expired - Lifetime
- 1998-06-22 CA CA002294744A patent/CA2294744C/en not_active Expired - Fee Related
- 1998-06-22 US US09/125,933 patent/US6284271B1/en not_active Expired - Fee Related
- 1998-06-22 JP JP50700999A patent/JP2002508781A/ja not_active Ceased
- 1998-06-22 DE DE69817587T patent/DE69817587T2/de not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4844905A (en) * | 1986-02-24 | 1989-07-04 | Eisai Co., Ltd. | Granule remaining in stomach |
| EP0257310B1 (en) * | 1986-07-28 | 1992-01-08 | Bio -Dar Ltd. | Tablets made from sustained release microcapsules |
Also Published As
| Publication number | Publication date |
|---|---|
| SE9702533D0 (sv) | 1997-07-01 |
| US6284271B1 (en) | 2001-09-04 |
| CA2294744A1 (en) | 1999-01-14 |
| JP2002508781A (ja) | 2002-03-19 |
| DE69817587T2 (de) | 2004-06-24 |
| ATE247952T1 (de) | 2003-09-15 |
| CA2294744C (en) | 2006-10-17 |
| EP1014952B1 (en) | 2003-08-27 |
| WO1999001112A1 (en) | 1999-01-14 |
| AU8135798A (en) | 1999-01-25 |
| DE69817587D1 (de) | 2003-10-02 |
| EP1014952A1 (en) | 2000-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1014952B1 (en) | Multiple unit effervescent dosage form | |
| EP1809251B1 (en) | Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane | |
| US6749867B2 (en) | Delivery system for omeprazole and its salts | |
| TWI240637B (en) | Oral pharmaceutical pulsed release dosage form | |
| EP0277127B1 (en) | New drug preparation with controlled release of the active compound, and a method for the manufacture thereof | |
| RU2201223C2 (ru) | Фармацевтическая композиция из множества субъединиц и способ ее получения | |
| EP1802285B1 (en) | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers | |
| JP5604304B2 (ja) | 口腔内崩壊性固形製剤 | |
| EP0235718B1 (en) | Granule remaining in stomach | |
| JPWO2008081891A1 (ja) | 口腔内崩壊性固形製剤 | |
| KR20080098627A (ko) | 약 염기성 선택성 세로토닌 5-ht3 차단제와 유기산을 포함하는 약물 전달 시스템 | |
| KR20030013460A (ko) | 치료제의 위 체류 및 방출 조절을 위한 급속 팽창성조성물과 이 조성물을 포함하는 제형 | |
| JP2002530322A5 (cg-RX-API-DMAC10.html) | ||
| EP1596838A2 (en) | Once a day orally administered pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent | |
| JP2008540437A (ja) | キニーネを含有する制御放出調合剤 | |
| AU2003218701A1 (en) | Medicaments containing active ingredients which lower the level of cholesterol with time-delayed active ingredient release | |
| IE840146L (en) | Pinacidil preparation | |
| JPS61221116A (ja) | 錠剤の組成物 | |
| AU2004200325B2 (en) | Oral Pulsed Dose Drug Delivery System | |
| AU2006236052B2 (en) | Oral pulsed dose drug delivery system | |
| HK1107272B (en) | Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane | |
| HK1154515A (en) | Taste-masked multiparticulate pharmaceutical composition comprising a drug-containing core particle and a solvent-coacervated membrane | |
| HK1109337B (en) | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers | |
| HK11494A (en) | New drug preparation with controlled release of the active compound, and a method for the manufacture thereof | |
| MXPA99002404A (en) | Controlled release dosage form of [r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2. 2]oct-3-yl)acetonitrile monohydrochloride |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TC | Change of applicant's name (sec. 104) |
Owner name: ASTRAZENECA AB Free format text: FORMER NAME: ASTRA AKTIEBOLAG |
|
| FGA | Letters patent sealed or granted (standard patent) |